Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

'Hero of COVID Crisis' Dr. Praveen Buddiga Takes Home Slew of Awards, Recognizing Advances in Skin Immunology and Combating Pandemic
  • USA - English

In 2021, Dr. Buddiga oversaw the launch of BUDDIGA Skin Aesthetics, pioneering a novel perspective to skincare and anti-aging called 'Skin Immunology'


News provided by

Buddiga Skin Aesthetics

Jan 05, 2022, 12:00 ET

Share this article

Share toX

Share this article

Share toX

FRESNO, Calif., Jan. 5, 2022 /PRNewswire-PRWeb/ -- As one of the world's chief immunologists and distinguished medical experts, Dr. Praveen Buddiga has dedicated the lion's share of his energy and passion to advancing public health in the fields of immunology, allergy, and asthma. 2021 was of course no exception.

For one, he oversaw the launch of his practice's new division, BUDDIGA Skin Aesthetics, pioneering a novel perspective to skincare and anti-aging, through his holistic, scientific-based approach he has termed 'Skin Immunology.'

In June, Dr. Buddiga was lauded as one of this country's "Heroes of the COVID Crisis" by Authority Magazine for leading the way during the pandemic and navigating Americans through the most challenging of times during the COVID-19 pandemic, from the very beginning.

Serving as chief medical correspondent on popular daily news programs such as Good Day LA and others, Dr. Buddiga contributed much of his time providing education to the public about social health measures.

And through a major initiative he led in partnership with the California Department of Public Health, he rolled out an organized testing program, and expeditiously deployed thousands of vaccines into the arms of California's adults & children as well as the most vulnerable members of our society.

Recognizing his mammoth contributions to public health and his division's achievements, he recently became the recipient of a half-dozen awards.

In December, his practice took home the 2021 Centauri Award in the Vega Awards program in the category of 'Healthcare Services.'

He also earned two Gold Awards: one from the 2021 Muse Awards and another in the 2021 Davey Awards. Additionally, he garnered the Platinum Award, the highest honor from the 2021 Marcom Awards, for his medical practice.

In addition to educating members of the public through his social media channels, and as an expert medical contributor on television, Dr. Buddiga also conducted a number of webinars focused on teaching fellow physicians and other health professionals about the COVID-19 pandemic, starting at the very beginning of the virus in early 2020.

Although reticent to hold the mantle of the 'hero' title, Dr. Buddiga stated in his interview with Authority Magazine, "The catalysts that prompted me to take action were the command of my knowledge in immunology and to assist doctors and health professionals to navigate questions regarding the contagion, its process of spread, and advocating prevention measures such as masking, handwashing, social distancing and eventually the vaccination effort to eradicate this disease."

In 2022, Dr. Buddiga will continue to shepherd all of us through the highs and lows of the existing pandemic, currently experiencing an explosive surge of cases due to the Omicron variant.

As the COVID-19 virus becomes more endemic and less of a threat to our everyday lives, more Americans will begin returning to physical work and social environments.

Thanks to Dr. Buddiga's cutting-edge approach to skin immunology, they can look forward to reviving their skin health through BUDDIGA Skin Aesthetics' world-class skincare treatments.

This includes the highly advanced OPUS Plasma Skin Resurfacing, as well as the Hydrafacial MD Elite™, in addition to other advanced technological FDA approved modalities focused on restoring and improving the most active organ of the immune system, known as skin. Some of the most popular requests are explained below:

NON-INVASIVE BODYSCULPTING - Improved skin health and appearance via excess fat reduction. They have the latest generation of FDA approved devices - COOLSCULPTING ELITE™ to reduce unwanted fat for up to 24 % after 3 treatment cycles.

NON-INVASIVE MUSCLE TONING and STRENGTH – FDA approved EMSCULPT NEO™ by BTL Aesthetics uses the latest non-invasive technology HIFEM = High Intensity focused electromagnetic technology in combination with Radiofrequency to strengthen & tone muscle with an added benefit of fat reduction. Patients who underwent this treatment state they sit up straighter, feel better and improve in sports – anecdotal unsolicited comments have been that "backs don't hurt as much, posture is better," they can hold the "plank" longer and they are better at yoga, pilates, golf drives, tennis serves, and the list goes on. Overall, the authors of the lead study were impressed by the improvement in strength and endurance performance.

Other non- or minimally invasive treatments for patients include Botox and dermal filler injectables to reverse the signs of aging, such as wrinkles and fine lines.

For more information on Dr. Praveen Buddiga and BUDDIGA Skin Aesthetics, visit his official website at http://www.BUDDIGA.com or call (559) 421-9009.

Follow Dr. Buddiga at:
Instagram - @DrPraveenBuddiga
Facebook - @FamilyAllergyAsthmaClinic
Twitter - @DrFamilyAllergy
LinkedIn- @DrPraveenBuddiga

Media Contact

Steven LeVine, Brandi Kamenar Beverly Hills, +1 323-386-2300 Ext: 1, [email protected]

SOURCE Buddiga Skin Aesthetics

Modal title

Dr. Praveen Buddiga
Dr. Praveen Buddiga
Dr. Praveen Buddiga

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.